Journal List > Kosin Med J > v.28(1) > 1057012

Choi and Kim: Nutritional Treatment: New Strategy for Management of Chronic Pelvic Pain

Abstract

Chronic pelvic pain is a common condition in women of reproductive age and can be described as chronic nociceptive, inflammatory and neuropathic pain characterized by spontaneous pain or a response to various stimuli. Oxidative stress is a component of the inflammatory reaction associated with pain processes. Iron and NF-κ B are well-known inducers of oxidative stress, and reactive oxygen species (ROS) are associated with chronic pelvic pain and play an important role in the regulation of genes expressing immunoregulators, cytokines, and other molecules. Chronic pelvic pain treatment is often unsatisfactory and limited to symptom control. However, dietary treatment with antioxidants can improve the function of the immune system and overcome free radical damage. Therefore, dietary supplementation is suggested as a means to treat some chronic medical conditions that respond poorly to medication. In summary, dietary treatment with antioxidants could be considered for new strategy for treatment of chronic pelvic pain and may be better tolerated by patients than current treatments.

REFERENCES

1.Cheong Y., William Stones R. Chronic pelvic pain: aetiology and therapy. Best Pract Res Clin Obstet Gynaecol. 2006. 20:695–711.
crossref
2.Gelbaya TA., El-Halwagy HE. Focus on primary care: chronic pelvic pain in women. Obstet Gynecol Surv. 2001. 56:757–64.
crossref
3.Gupta S., Agarwal A., Sekhon L., Krajcir N., Cocuzza M., Falcone T. Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers. Minerva Ginecol. 2006. 58:527–51.
4.Stones RW., Mountfield J. Interventions for treating chronic pelvic pain in women. Cochrane Database Syst Rev. 2000. 4:CD000387.
crossref
5.Sesti F., Capozzolo T., Pietropolli A., Collalti M., Bollea MR., Piccione E. Dietary therapy: a new wtrategy for management of chronic pelvic pain. Nutr Res Rev. 2010. 25:1–8.
6.Howard FM. An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies. J Am Assoc Gynecol Laparosc. 2000. 7:477–88.
crossref
7.Hippeli S., Elstner EF. Transitional metal ion-catalyzed oxygen activation during pathogenic processes. FEBS Lett. 1999. 443:1–7.
8.Guo SW. Nuclear factor-kappa b (NF-κB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? Gynecol Obstet Invest. 2007. 63:71–97.
9.Ota H., Igarashi S., Tnaka T. Xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril. 2001. 75:785–90.
crossref
10.Xi G., Keep RF., Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006. 5:53–63.
crossref
11.Lousse JC., Van Langendonckt A., González-Ramos R., Defrère S., Renkin E., Donnez J. Increased activation of nuclear factor-kappa B (NF-kappaB) in isolated peritoneal macrophages of patients with endometriosis. Fertil Steril. 2008. 90:217–20.
12.Montagna P., Capellino S., Villaggio B., Remorgida V., Ragni N., Cutolo M, et al. Peritoneal fluid macrophages in endometriosis: correalation between the expression of estrogen receptors and inflammation. Fertil Steril. 2008. 90:156–64.
13.Liu NQ., Kaplan AT., Lagishetty V., Ouyang YB., Ouyang Y., Simmons CF, et al. Vitamin D and the regylation of placental inflammation. J Immunol. 2011. 186:5968–74.
14.Halhali A., Figueras AG., Díaz L., Avila E., Barrera D., Hernández G, et al. Effects of calcitriol on calbindins gene expression and lipid peroxidation in human placenta. J Steroid Biochem Mol Biol. 2010. 121:448–51.
crossref
15.Van Langendonckt A., Casanas-Roux F., Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril. 2002. 77:861–70.
crossref
16.Kruse HD., Orent ER., McCollum EV. Studies on magnesium deficiency in animals: I. Symptomatology resulting from Mg deprivation. J Biol Chem. 1932. 96:519–39.
17.Haury VG., Cantarow A. Variations of serum magnesium in 52 normal and 440 pathologic patients. J Lab Clin Med. 1942. 27:616–22.
18.Saris NE., Mervaala E., Karppanen H., Khawaja JA., Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000. 294:1–26.
19.Kanbay M., Goldsmith D., Uyar ME., Turgut F., Covic A. Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif. 2010. 29:280–92.
crossref
20.Chaumais MC., Lecerf F., Fattal S., Savale L., Günther S., Huertas A, et al. A study of magnesium deficiency in human and experimental pulmonary hypertension. Magnes Res. 2012. 25:21–7.
crossref
21.Dowling O., Chatterjee PK., Gupta M., Tam Tam HB., Xue X., Lewis D, et al. Magnesium sulfate reduces bacterial LPS-induced inflammation at the maternal-fetal interface. Placenta. 2012. 33(5):392–8.
crossref
22.Rayssiguier Y., Mazur A. Magnesium and inflammation: lessons from animal models. Clin Calcium. 2005. 15:245–8.
23.Murphy AA., Santanam N., Parthasarathy S. Endometriosis: a disease of oxidative stress? Semin Reprod Endocrinol. 1998. 16:263–73.
crossref
24.Murphy AA., Santanam N., Morales AJ., Parthasarathy S. Lyso-phosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. J Clin Endocrinol Metab. 1998. 83(6):2110–3.
crossref
25.Campos Petean C., Ferriani RA., dos Reis RM., de Moura MD., Jordão AA Jr., Navarro PA. Lipid peroxidation and vitamin E in serum and follicular fluid of infertile women with peritoneal endometriosis submitted to controlled ovarian hyperstimulation: a pilot study. Fertil Steril. 2008. 90:2080–5.
26.Mier-Cabrera J., Genera-García M., De la Jara-Díaz J., Perichart-Perera O., Vadillo-Ortega F., Hernández-Guerrero C. Effect of vitamins C and E supplementation on peripheral oxidative stress markers and pregnancy rate in women with endometriosis. Int J Gynaecol Obstet. 2008. 100:252–6.
TOOLS
Similar articles